Genetic Markers of Toxicity From Capecitabine and Other Fluorouracil-Based Regimens: Investigation in the QUASAR2 Study, Systematic Review, and Meta-Analysis

Autor: Sargent, Daniel, Gonzalez-Neira, Anna, Johnstone, Elaine, Seymour, Matthew, Schwab, Matthias, Boige, Valérie, Milano, Gérard, Nicholson, George, Zanger, Ulrich M., Green, Erin, Scudder, Claire, Jensen, Søren Astrup, Wadelius, Mia, Lacas, Benjamin, Garmo, Hans, Martin, Miguel, Love, Sharon, Afzal, Shoaib, Ribelles, Nuria, Thompson, Lindsay, Enghusen, Henrik, McLeod, Howard, Church, David, Palles, Claire, Glimelius, Bengt, Wang, Haitao, Domingo, Enric, Braun, Michael, Rosmarin, Dan, Etienne-Grimaldi, Marie-Christine, Jones, Angela, Julier, Patrick
Jazyk: angličtina
Rok vydání: 2014
Předmět:
DOI: 10.17615/00b1-8a23
Popis: Fluourouracil (FU) is a mainstay of chemotherapy, although toxicities are common. Genetic biomarkers have been used to predict these adverse events, but their utility is uncertain.
Databáze: OpenAIRE